Asceneuron S.A.
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of ASN51 in Adults With Early Alzheimer's Disease (NCT06677203) | Asceneuron S.A. | 2024-10-16 |
| Drug-Drug Interaction of ASN51 With Fluvoxamine, Itraconazole and Paroxetine in Healthy Subjects (NCT06232109) | Asceneuron S.A. | 2024-02-22 |
| PET Study of Repeated ASN51 in Healthy Volunteers (NCT05725005) | Asceneuron S.A. | 2023-01-26 |
| Positron Emission Tomography Study in Healthy Subjects to Determine the Relationship Between Plasma Concentration and Brain Target Occupancy of ASN51 (NCT06390098) | Asceneuron S.A. | 2021-08-09 |
Track Asceneuron S.A. automatically
Every clearance here is in the API, with alerts when new ones post.